Abstract

<h3>Introduction</h3> Patient-reported outcome measures (PROMs) are useful tools for monitoring chronic urticaria (CU) and atopic dermatitis (AD), but at the same time their use present different challenges, so the present study aims to identify the main barriers perceived by allergists treating AD and UC regarding the use of PROMs. <h3>Methods</h3> A cross-sectional study using a web-based survey sent to allergists worldwide. We performed U-Mann-Whitney and binary logistic regression tests using SPSS Statistics to compare the results between the groups, a p<0.05 was considered significant. <h3>Results</h3> We had a total of 546 allergists, 56.6% were female, 13.7% were from Mexico, 13.2% from Russia and 8.8% from Iran. They had a median of 48 years old and a median of 20 years of specialty. The most common barriers were: time constrains, lack of integration into clinical systems and not availability for certain age groups. Logistic regression demonstrated that treating CU was associated with increased odds of "Time Constrains" barrier (OR=0.93; 95% CI = 0.89-0.96, p: 0.001). On the other hand, treating AD increase the odds of the second barrier (OR=1.12; 95% CI = 1.07-1.18, p: 0.000). <h3>Conclusion</h3> Lack of time has been described as one of the biggest barriers to routine PROMs use in the allergy setting. It is imperative to reinforce the dissemination of new tools online or facilitate their integration into clinical systems to reduce the time spent filling out PROMs.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.